Danzhou Yang

Title: Danzhou Yang: Innovator in Oligonucleotide Delivery Systems

Introduction

Danzhou Yang is a prominent inventor based in Lexington, KY (US). He has made significant contributions to the field of drug delivery systems, particularly in the area of camptothecin drugs. His innovative approach combines gene therapy with drug therapy, showcasing the potential for enhanced cancer treatment.

Latest Patents

Danzhou Yang holds 1 patent for his invention titled "Oligonucleotide delivery systems for camptothecins." This patent describes a method where camptothecin drugs are stabilized in their antitumor active lactone form through complexation with an oligonucleotide, which may include RNA or catalytic RNA. The oligonucleotide-camptothecin drug complex can be incorporated within a macromolecular assembly, utilizing both viral and non-viral oligonucleotide vectors. This invention allows for the combination of gene therapy and camptothecin drug therapy, potentially improving treatment outcomes for cancer patients.

Career Highlights

Danzhou Yang is affiliated with the University of Kentucky Research Foundation, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in the medical field, particularly in oncology.

Collaborations

Some of his notable coworkers include Thomas G Burke and Ayhan S Demir, who have contributed to the research and development of his innovative projects.

Conclusion

Danzhou Yang's contributions to oligonucleotide delivery systems represent a significant advancement in cancer therapy. His innovative approach has the potential to improve treatment efficacy and patient outcomes.